Recent Myeloma ResearchExplore Recent Findings in Myeloma Research
See why aiming for MRD negativity may be an optimal strategy for patients with high-risk cytogenetics.
![MRD negativity strategy for patients with high-risk cytogenetics, Downloadable resource. MRD negativity strategy for patients with high-risk cytogenetics, Downloadable resource.](/images/findings-img1.png)
Review evidence of the importance of frailty assessment when treating the ageing patient with myeloma.
![The importance of frailty assessment when treating ageing patient with Multiple Myeloma, Downloadable resource. The importance of frailty assessment when treating ageing patient with Multiple Myeloma, Downloadable resource.](/images/findings-img2.png)
Learn about how high attrition rates underscore the importance of maximising PFS in early lines of therapy.
![High attrition rates and the importance of using your best therapy first, Downloadable resource. High attrition rates and the importance of using your best therapy first, Downloadable resource.](/images/findings-img3.png)
MRD=minimal residual disease.